{
    "root": "34f7a1a5-66bf-5930-e063-6394a90a26ac",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clindamycin Phosphate",
    "value": "20250512",
    "ingredients": [
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "CLINDAMYCIN PHOSPHATE",
            "code": "EH6D7113I8"
        }
    ],
    "indications": "Clindamycin Phosphate Topical Solution USP, 1% is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see\n \n  \n                        CONTRAINDICATIONS,\n  \n   WARNINGS\n                     and\n \n  \n                        ADVERSE REACTIONS\n                     ).",
    "contraindications": "Apply a thin film of Clindamycin Phosphate Topical Solution USP, 1% twice daily to affected area. Keep container tightly closed.",
    "warningsAndPrecautions": "Clindamycin Phosphate Topical Solution USP, 1% is available as follows:\n                  30 mL applicator bottle (NDC 72162-1418-03).\n                  60 mL applicator bottle (NDC 72162-1418-06).\n                  Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature]. Protect from freezing.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions": "Clindamycin Phosphate Topical Solution USP, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis."
}